ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,425Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 12

$592K Total Retail Price of All Prescriptions

Rank: 3 out of 12

171 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 171 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 9,864 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

61 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
POTASSIUM CHLORIDE 523 505 1 6
FUROSEMIDE 466 462 2 4
NAMENDA 415 415 3 10
LEVOTHYROXINE SODIUM 388 386 4 1
AMLODIPINE BESYLATE 291 261 5 5
LISINOPRIL 279 268 6 3
WARFARIN SODIUM 271 219 7 14
SIMVASTATIN 235 231 8 7
MIRTAZAPINE 217 217 9 16
DONEPEZIL HCL 197 197 10 13
TRAMADOL HCL 192 183 11 20
GABAPENTIN 186 183 12 9
METOPROLOL TARTRATE 167 149 13 11
ALENDRONATE SODIUM 164 158 14 23
SUCRALFATE 123 123 15 46
BUSPIRONE HCL 118 113 16 47
DIGOXIN 117 104 17 63
RISPERIDONE 116 116 18 43
MELOXICAM 106 102 19 24
OMEPRAZOLE 106 104 19 8
CLOPIDOGREL 105 105 21 33
PLAVIX 104 104 22 34
DIVALPROEX SODIUM 102 102 23 88
IBANDRONATE SODIUM 102 102 23 88
HYDROCODONE-ACETAMINOPHEN 101 81 S3 25 2
GALANTAMINE HBR 100 100 26 92
PANTOPRAZOLE SODIUM 100 91 26 71
METOPROLOL SUCCINATE 93 93 28 18
GLIPIZIDE 90 90 29 40
SERTRALINE HCL 90 81 29 32
CEFTRIAXONE 87 85 31 97
LYRICA 84 63 32 73
ATENOLOL 84 61 32 19
ISOSORBIDE MONONITRATE ER 82 82 34 44
SODIUM CHLORIDE 81 81 35 59
SPIRONOLACTONE 79 76 36 76
CARVEDILOL 79 79 36 28
ESCITALOPRAM OXALATE 77 65 38 35
LIDOCAINE HCL 74 73 39 103
AZELASTINE HCL 73 73 40 104
ATORVASTATIN CALCIUM 73 72 40 26
ALBUTEROL SULFATE 71 69 42 106
METFORMIN HCL 67 67 43 15
LEVOFLOXACIN 64 58 44 83
ENABLEX 62 62 45 85
BONIVA 62 62 45 110
DILTIAZEM ER 59 59 47 113
HYDROCHLOROTHIAZIDE 57 57 48 17
SINGULAIR 57 57 48 63
TRAZODONE HCL 56 56 50 27
PAROXETINE HCL 54 54 51 74
ACTONEL 53 53 52 125
HUMULIN R 52 52 53 128
LEVETIRACETAM 52 37 53 88
OLANZAPINE 51 51 55 129
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 48 56 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 10, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.